Sinopharm
1099.HK
#2770
Rank
NZ$10.91 B
Marketcap
NZ$3.50
Share price
-1.92%
Change (1 day)
-19.51%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

EPS for Sinopharm (1099.HK)

EPS in 2024 (TTM): NZ$0.11

According to Sinopharm's latest financial reports the company's current EPS (TTM) is NZ$0.55. In 2025 the company made an earnings per share (EPS) of NZ$0.55 an increase over its 2024 EPS that were of NZ$0.52.

EPS history for Sinopharm from 2006 to 2024

Annual EPS

Year EPS Change
2025NZ$0.555.7%
2024NZ$0.52-24.52%
2023NZ$0.693.65%
2022NZ$0.661.3%
2021NZ$0.6610.33%
2020NZ$0.5917.26%
2019NZ$0.515.44%
2018NZ$0.48-0.87%
2017NZ$0.4919.44%
2016NZ$0.4115.3%
2015NZ$0.3517.06%
2014NZ$0.3021.9%
2013NZ$0.2511.82%
2012NZ$0.2225.24%
2011NZ$0.1831.02%
2010NZ$0.133.3%
2009NZ$0.1346.85%
2008NZ$0.0887167.57%
2007NZ$0.05294310.24%
2006NZ$0.01291